Human immunodeficiency virus-related neurocognitive disorder with hallucinations and delusions: A case report
Psychiatry Research Case Reports, ISSN: 2773-0212, Vol: 3, Issue: 1, Page: 100201
2024
- 5Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures5
- Readers5
Case Description
In patients with human immunodeficiency virus (HIV) infection, HIV-associated neurocognitive disorder (HAND) manifests in 18–50% of cases. Symptoms, including memory impairment, impaired attention, concentration, executive dysfunction, slowed motor speed, apathy, personality changes, and abnormal behavior can vary. However, psychotic symptoms, such as hallucinations and delusions, are rare. We report a case of HAND with hallucinations, delusions, abnormal behavior, irritability, and decreased motor and attention-processing speeds that were successfully treated with risperidone and aripiprazole. A 39-year-old Japanese man with a 6-year history of HIV infection presented to our hospital with delusions, hallucinations, and cognitive dysfunction. Five years ago, he was admitted to our department with abnormal behaviors, such as trespassing in a stranger's residence and immobility. He was diagnosed with HAND after ruling out opportunistic infections secondary to HIV infection and neurodegenerative diseases. He was initially admitted with auditory and visual hallucinations, which improved with risperidone 4 mg. However, 2 years ago, he discontinued risperidone and became irritable. He was admitted to our department in October of the same year with hallucinations, delusions, slow movement, and decreased spontaneity. Misperception, delusions, abnormal behavior, and prolonged response latency were observed at the time of admission. On the third day of admission, aripiprazole was administered, and the dose was titrated to 30 mg. His-hallucinations, delusions, abnormal behavior, and irritability disappeared. One year later, in March, a cognitive function test showed that his motor speed, attention-information processing speed, and activity had improved. This patient presented with HAND symptoms, such as hallucinations, delusions, abnormal behavior, hyperirritability, and cognitive dysfunction. Risperidone and aripiprazole effectively alleviated these symptoms, and the cognitive dysfunction showed reversible improvement. Clinicians should be aware of the possibility of rare symptoms, such as hallucinations and delusions, while treating HAND. Additionally, they should consider the possibility of improved cognitive function and provide appropriate treatments.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know